Article PDF
References
Sildenafil for erectile dysfunction. Drug Ther Bull 1998;36(11).
Marmor MR . Sildenafil (Viagra) and ophthalmology [editorial]. Arch OphthalmoI 1999;117:518–9.
Sildenafil. Summary of drug characteristics, UK and Ireland. Pfizer Limited, September 1998.
Vobig MA, Klotz T, Staak M, Bartz-Schmidt KU, Engelmann U, Walter P . Retinal side-effects of sildenafil. Lancet 1999;353:375.
Kloner RA, Zusman RM . Cardiovascular effects of sildenafil citrate and recommendations for its use. Am J Cardiol 1999;84:N11–7.
Morales A, Gingell C, Collins M, Wicker PA, Osterloh IH . Clinical safety of oral sildenafil (Viagra) in the treatment of erectile dysfunction. Int J Impot Res 1998;10:69–74.
Morbidelli L, Chang CH, Douglas JG, Granger HI, Ledda F, Ziche M . Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium. Am J Physiol 1996;270:H411–5.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Burton, A., Reynolds, A. & O'Neill, D. Sildenafil (Viagra) a cause of proliferative diabetic retinopathy?. Eye 14, 785 (2000). https://doi.org/10.1038/eye.2000.205
Issue Date:
DOI: https://doi.org/10.1038/eye.2000.205